SCHEMBL3624311

SCHEMBL3624311

COC(C(=O)N1CCNCC1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 1/20 0.52
RAB9A P51151 2/20 0.52
OPRD1 P41143 3/20 0.49
SIGMAR1 Q99720 1/20 0.49
MAPK1 P28482 1/20 0.47
AURKA O14965 3/20 0.45
ABL1 P00519 3/20 0.45
NTRK1 P04629 3/20 0.45
RET P07949 3/20 0.45
FGFR1 P11362 3/20 0.45
AURKB Q96GD4 3/20 0.45
BCR P11274 2/20 0.45
PLK4 O00444 2/20 0.45
JAK2 O60674 2/20 0.45
MAP4K4 O95819 2/20 0.45
LCK P06239 2/20 0.45
FYN P06241 2/20 0.45
FES P07332 2/20 0.45
LYN P07948 2/20 0.45
SRC P12931 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL25272684 0.98 CHRM1 (0.51) CHRM1RAB9AOPRD1SIGMAR1MAPK1
Hydrochloric Acid SCHEMBL25272683 0.98 CHRM1 (0.51) CHRM1RAB9AOPRD1SIGMAR1MAPK1
SCHEMBL21907373 0.86 CHRM1 (0.56) CHRM1RAB9AMAPK1KMT2AMEN1
SCHEMBL22188711 0.85 RAB9A (0.41) CHRM1RAB9AOPRD1SIGMAR1AURKA
SCHEMBL13865331 0.84 CHRM1 (0.55) CHRM1RAB9AMAPK1KMT2AMEN1
SCHEMBL18390251 0.83 CHRM1 (0.74) CHRM1RAB9AMAPK1AURKAABL1
SCHEMBL12282147 0.82 KMT2A (0.62) CHRM1RAB9AMAPK1KMT2AMEN1
SCHEMBL18390271 0.81 CHRM1 (0.60) CHRM1RAB9AMAPK1KMT2AMEN1
SCHEMBL16207602 0.80 SIGMAR1 (0.53) CHRM1OPRD1SIGMAR1POLBKMT2A
SCHEMBL16207601 0.80 SIGMAR1 (0.53) CHRM1OPRD1SIGMAR1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004252-A1 SUBSTITUTED TETRAHYDROPYRROLOPYRAZINE COMPOUNDS AND THE USE THEREOF IN THE TREATMENT AND/OR INHIBITION OF PAIN GRUENENTHAL GMBH (DE) 2010-01-07 US disclosed
US-7625900-B2 Sutstituted tetrahydropyrrolopyrazine compounds and the use thereof in the treatment and/or inhibition of pain GRUENENTHAL GMBH (DE) 2009-12-01 US disclosed
US-20080167315-A1 Substituted Tetrahydropyrrolopyrazine Compounds and the Use Thereof in the Treatment and/or Inhibition of Pain GRUENENTHAL GMBH (DE) 2008-07-10 US disclosed
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed
US-4775673-A Substituted acylpiperazinoquinazolines and pharmaceutical compositions containing same SPOFA, SPOJENE PODNIKY PRO ZDRAVOTNICKOU VYROBU (CZ) 1988-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT CHRM1 4601/4885RAB9A 4278/4885OPRD1 4268/4885
US-20100004252-A1 SUBSTITUTED TETRAHYDROPYRROLOPYRAZINE COMPOUNDS AND THE USE THEREOF IN THE TREATMENT AND/OR INHIBITION OF PAIN KCNQ2, KCNQ1, KCNJ2 CHRM1 1836/4885RAB9A 3709/4885OPRD1 227/4885
US-20080167315-A1 Substituted Tetrahydropyrrolopyrazine Compounds and the Use Thereof in the Treatment and/or Inhibition of Pain KCNQ2, KCNQ1, KCNJ2 CHRM1 1836/4885RAB9A 3709/4885OPRD1 227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.